Investigators Using ASCQ-Me
Shannon Kelly, MD
Blood Systems Research Institute
Recipient Epidemiology and Donor Evaluation Study-II (REDS-II)
Josh Lehrer, M.Phil., M.D., FACC
Global Blood Therapeutics
Phase I/II trial GBT440 Anti-Sickling Hemoglobin Modifier
Wally R. Smith, MD
Virginia Commonwealth University
Enhancing Use of Hydroxyurea in Sickle Cell Disease Using Patient Navigators (SHiP HU)
Marsha J. Treadwell, PhD
UCSF Benioff Children's Hospital Oakland
Sickle Cell Disease Clinical Data Research Network
Useful Links
Resources and information for sickle cell disease patients, families and their caregivers: